Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
83,642,522
-
Share change
-
-8,523,667
-
Total reported value
-
$11,343,827,073
-
Put/Call ratio
-
208%
-
Price per share
-
$135.65
-
Number of holders
-
633
-
Value change
-
-$1,167,937,751
-
Number of buys
-
309
-
Number of sells
-
238
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q1 2021
As of 31 Mar 2021,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
633 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
83,642,522 shares.
The largest 10 holders included
MORGAN STANLEY, GOLDMAN SACHS GROUP INC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, BANK OF AMERICA CORP /DE/, JPMORGAN CHASE & CO, BNP PARIBAS ARBITRAGE, SA, CITIGROUP INC, UBS Group AG, BARCLAYS PLC, and WELLS FARGO & COMPANY/MN.
This page lists
638
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.